After founding the "Google for LLMs," You.com, Richard Socher's next company, Recursive AI, could automate AI research itself ...

Backed by a $1M+ commercial license and 1B+ solutions evaluated, Project 777 is moving frontier AI from raw model ...

Major release delivers seamless Ignition SCADA, enterprise-grade security, advanced ML algorithms, and private cloud ...

Infosecurity outlines key recommendations for CISOs and security teams to implement safeguards for AI-assisted coding ...

The Democratic Republic of Congo (DRC) today is caught in a convulsive spiral of violence and institutional decay that lays bare a cruel paradox of both subterranean abundance and surface‑level ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Great. Thanks, everyone, for joining. My name is Scott Schoenhaus. I am the health care tech equity analyst here at KeyBanc. We're a pleasure to have Ben Taylor, CFO of Recursion for a fireside chat.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer answered questions about. When a caller mentioned that Cathie Wood invested in the stock, Cramer remarked, “That’s, it’s a ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...